homehealthcare News

Canada says AstraZeneca vaccine is safe after Norway and Denmark suspend use

Canada says AstraZeneca vaccine is safe after Norway and Denmark suspend use

Canada says AstraZeneca vaccine is safe after Norway and Denmark suspend use
Profile image

By Reuters Mar 12, 2021 11:17:58 AM IST (Updated)

Canada on Thursday said the AstraZeneca COVID19 vaccine is safe after Denmark and Norway temporarily suspended its use amid reports that blood clots had formed in some who had received the shot.

Canada on Thursday said the AstraZeneca COVID-19 vaccine is safe after Denmark and Norway temporarily suspended its use amid reports that blood clots had formed in some who had received the shot. ”Health Canada is aware of reports of adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine, and would like to reassure Canadians that the benefits of the vaccine continue to outweigh its risks,” the health department said in a statement.

Recommended Articles

View All

”At this time, there is no indication that the vaccine caused these events,” it said.
Canada received 500,000 AstraZeneca doses made at the Serum Institute of India last week and expects to get 1.5 million more in by May.
”To date, no adverse events related to the AstraZeneca COVID-19 vaccine… have been reported to Health Canada or the Public Health Agency of Canada,” the statement said.
The federal government has ordered a total of 20 million doses of the AstraZeneca vaccine and is due to receive 1.9 million through COVAX – the international initiative set up to provide equitable access to vaccines.
Also Read
Although Canada has ordered more COVID-19 vaccine doses per capita any other country, its initial roll-out has been slow in part because of temporary disruptions of deliveries from Pfizer Inc. and Moderna Inc.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng